BSEM Share Price Performance

BSEM Community Fair Values

AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion
Key Takeaways Strategic collaborations and successful CMS partnerships can enhance market adoption and pricing stability, boosting net margins and profitability. Expanding clinical trials and NASDAQ uplisting may increase revenue, earnings, and shareholder value through broader market access and investor reach.
US$49.56
FV
76.8% undervalued intrinsic discount
27.09%
Revenue growth p.a.
0users have liked this narrative
2users have commented on this narrative
16users have followed this narrative
4 months ago author updated this narrative

View all narratives

Recent BSEM News & Updates

No updates

BioStem Technologies, Inc. Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

Aug 14, 2025

Earnings per share (EPS): 1.98
Gross Margin: 96.28%
Net Profit Margin: 9.96%
Debt/Equity Ratio: 8.5%

View full report ›

BioStem Technologies, Inc. Competitors

View more competitors

About BSEM

Founded: 2006
Employees: n/a
CEO: Jason Matuszewski
WebsiteView website: www.biostemtechnologies.com

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

U.S. Market Performance

7 Days: 0.8%
3 Months: 15.1%
1 Year: 17.5%
Year to Date: 8.2%

Over the last 7 days, the market has remained flat, although notably the Energy sector gained 3.9% in that time. As for the longer term, the market has risen 17% in the past 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›

Who Will Win In The Age Of Agentic AI

Bailey Pemberton

July 2025

Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...

Last Week

BioStem Technologies Stock Price